These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7775593)

  • 1. RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3.
    Yen A; Varvayanis S
    J Cell Physiol; 1995 Jun; 163(3):502-9. PubMed ID: 7775593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing c-FMS (CSF-1 receptor) expression decreases retinoic acid concentration needed to cause cell differentiation and retinoblastoma protein hypophosphorylation.
    Yen A; Sturgill R; Varvayanis S
    Cancer Res; 1997 May; 57(10):2020-8. PubMed ID: 9158000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyomavirus small t antigen prevents retinoic acid-induced retinoblastoma protein hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis.
    Yen A; Placanica L; Bloom S; Varvayanis S
    J Virol; 2001 Jun; 75(11):5302-14. PubMed ID: 11333911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMS (CSF-1 receptor) prolongs cell cycle and promotes retinoic acid-induced hypophosphorylation of retinoblastoma protein, G1 arrest, and cell differentiation.
    Yen A; Sturgill R; Varvayanis S; Chern R
    Exp Cell Res; 1996 Nov; 229(1):111-25. PubMed ID: 8940255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor.
    Yen A; Soong S
    Eur J Cell Biol; 1996 Apr; 69(4):327-34. PubMed ID: 8741214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
    Yen A; Roberson MS; Varvayanis S; Lee AT
    Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation.
    Yen A; Fenning R; Chandraratna R; Walker P; Varvayanis S
    Mol Pharmacol; 2004 Dec; 66(6):1727-37. PubMed ID: 15383624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid induces expression of SLP-76: expression with c-FMS enhances ERK activation and retinoic acid-induced differentiation/G0 arrest of HL-60 cells.
    Yen A; Varvayanis S; Smith JL; Lamkin TJ
    Eur J Cell Biol; 2006 Feb; 85(2):117-32. PubMed ID: 16439309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late dephosphorylation of the RB protein in G2 during the process of induced cell differentiation.
    Yen A; Varvayanis S
    Exp Cell Res; 1994 Sep; 214(1):250-7. PubMed ID: 8082728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation.
    Yen A; Williams M; Platko JD; Der C; Hisaka M
    Eur J Cell Biol; 1994 Oct; 65(1):103-13. PubMed ID: 7889981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression.
    Yen A; Forbes ME; Varvayanis S; Tykocinski ML; Groger RK; Platko JD
    J Cell Physiol; 1993 Nov; 157(2):379-91. PubMed ID: 8227169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced cell differentiation when RB is hypophosphorylated and down-regulated by radicicol, a SRC-kinase inhibitor.
    Yen A; Soong S; Kwon HJ; Yoshida M; Beppu T; Varvayanis S
    Exp Cell Res; 1994 Sep; 214(1):163-71. PubMed ID: 7521842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a "status quo" gene.
    Yen A; Chandler S; Forbes ME; Fung YK; T'Ang A; Pearson R
    Eur J Cell Biol; 1992 Apr; 57(2):210-21. PubMed ID: 1511698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
    Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
    Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducers of leukemic cell differentiation cause down-regulation of RB gene expression.
    Yen A; Chandler S
    Proc Soc Exp Biol Med; 1992 Mar; 199(3):291-7. PubMed ID: 1539032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMSO, sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cell differentiation.
    Yen A; Varvayanis S
    In Vitro Cell Dev Biol Anim; 1995 Mar; 31(3):164-7. PubMed ID: 7757295
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative responsiveness of HL-60, HL-60R, and HL-60R+ (LRARSN) cells to retinoic acid, calcitriol, 9 cis-retinoic acid, and sodium butyrate.
    Atkins KB; Troen BR
    Blood; 1995 Oct; 86(7):2475-80. PubMed ID: 7670094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML/RAR alpha+ U937 mutant and NB4 cell lines: retinoic acid restores the monocytic differentiation response to vitamin D3.
    Testa U; Grignani F; Barberi T; Fagioli M; Masciulli R; Ferrucci PF; Seripa D; Camagna A; Alcalay M; Pelicci PG
    Cancer Res; 1994 Aug; 54(16):4508-15. PubMed ID: 7519122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
    Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
    Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
    Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
    Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.